Drug Recall


HPS Pharmacies wish to advise that Sanofi-Aventis Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:

Rifadin® 600mg Vials
Rifampicin 600mg
ARTG 156919

The only affected batch is: A5548 with an expiry date of September 2018.

This recall has been initiated due to contamination of the powder for injection with chilled water during manufacture.

Please inspect your stocks and quarantine all products from the affected batch for return to your supplier for a refund.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sanofi-Aventis Australia on (02) 8666 2000.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates